{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:47:28Z","timestamp":1789472848150,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00428-021-03048-y","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T16:32:02Z","timestamp":1613061122000},"page":"257-263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["GATA3 is a useful immunohistochemical marker for distinguishing sarcomatoid malignant mesothelioma from lung sarcomatoid carcinoma and organizing pleuritis"],"prefix":"10.1007","volume":"479","author":[{"given":"Zheng Hua","family":"Piao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Cheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"3048_CR1","unstructured":"Roggli V, Churg A, Chirieac LR, Galateau-Salle F, Borczuk A, Dacic S, Hammar S, Husain AN, Inai K, Ladanyi M, Marchevsky AM, Naidich D, Ordonez NG, Rice DC, Sheaff MT, Travis WD, van Meerbeeck J (2015) Sarcomatoid, desmoplastic, and biphasic mesothelioma. In: Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (eds) WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. World Health Organization Classification of Tumours 4th Edition, Lyon, pp 165\u2013168"},{"key":"3048_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1046\/j.1365-2559.2003.01583.x","volume":"42","author":"DR Lucas","year":"2003","unstructured":"Lucas DR, Pass HI, Madan SK, Adsay NV, Wali A, Tabaczka P, Lonardo F (2003) Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study. Histopathology 42:270\u2013279. https:\/\/doi.org\/10.1046\/j.1365-2559.2003.01583.x","journal-title":"Histopathology"},{"key":"3048_CR3","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1365-2559.2009.03298.x","volume":"54","author":"Y Takeshima","year":"2009","unstructured":"Takeshima Y, Amatya VJ, Kushitani K, Kaneko M, Inai K (2009) Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma. Histopathology 54:667\u2013676. https:\/\/doi.org\/10.1111\/j.1365-2559.2009.03298.x","journal-title":"Histopathology"},{"key":"3048_CR4","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jtho.2016.12.006","volume":"12","author":"Z Guo","year":"2017","unstructured":"Guo Z, Carbone M, Zhang X, Su D, Sun W, Lou J, Gao Z, Shao D, Chen J, Zhang G, Hu J, Chen K, Wang F, Pass HI, Yu H, Napolitano A, Yang H, Mao W (2017) Improving the accuracy of mesothelioma diagnosis in china. J Thorac Oncol 12:714\u2013723. https:\/\/doi.org\/10.1016\/j.jtho.2016.12.006","journal-title":"J Thorac Oncol"},{"key":"3048_CR5","doi-asserted-by":"publisher","first-page":"160e8","DOI":"10.1016\/j.humpath.2017.07.015","volume":"67","author":"AM Marchevsky","year":"2017","unstructured":"Marchevsky AM, LeStang N, Hiroshima K, Pelosi G, Pelosi G, Attanoos R, Churg A, Chirieac L, Dacic S, Husain A, Khoor A, Klebe S, Lantuejoul S, Roggli V, Vignaud JM, Weynand B, Sauter J, Henderson D, Nabeshima K, Francoise GS (2017) The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell\/pleomorphic (sarcomatoid) carcinomas of the lung: evidence based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center. Hum Pathol 67:160e8","journal-title":"Hum Pathol"},{"key":"3048_CR6","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1046\/j.1365-2559.2003.01674.x","volume":"43","author":"RL Attanoos","year":"2003","unstructured":"Attanoos RL, Gibbs AR (2003) \u2018Pseudomesotheliomatous\u2019 carcinomas of the pleura: a 10-year analysis of cases from the environmental lung disease research group, Cardiff. Histopathology 43:444\u2013452. https:\/\/doi.org\/10.1046\/j.1365-2559.2003.01674.x","journal-title":"Histopathology"},{"key":"3048_CR7","doi-asserted-by":"publisher","unstructured":"Liu H, Shi J, Wilkerson ML, Lin F (2012) Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol 138:57\u201364. https:\/\/doi.org\/10.1309\/AJCP5UAFMSA9ZQBZ","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ"},{"key":"3048_CR8","doi-asserted-by":"publisher","unstructured":"Miettinen M, McCue PA, Sarlomo-Rikala M, Rys J, Czapiewski P, Wazny K, Langfort R, Waloszczyk P, Biernat W, Lasota J, Wang Z (2014) GATA3: A multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol 38:13\u201322. https:\/\/doi.org\/10.1097\/PAS.0b013e3182a0218f","DOI":"10.1097\/PAS.0b013e3182a0218f"},{"key":"3048_CR9","doi-asserted-by":"publisher","unstructured":"Berg KB, Churg A (2017) GATA3 immunohistochemistry for distinguishing sarcomatoid and desmoplastic mesothelioma from sarcomatoid carcinoma of the lung. Am J Surg Pathol 41:1221\u20131225. https:\/\/doi.org\/10.1097\/PAS.0000000000000825","DOI":"10.1097\/PAS.0000000000000825"},{"key":"3048_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2020.08.005","volume":"105","author":"S Prabhakaran","year":"2020","unstructured":"Prabhakaran S, Hocking A, Kim C, Hussey M, Klebe S, Frcpa (2020) The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas. Hum Pathol 105:1\u20138. https:\/\/doi.org\/10.1016\/j.humpath.2020.08.005","journal-title":"Hum Pathol"},{"key":"3048_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/modpathol.2009.180","volume":"23","author":"S Klebe","year":"2010","unstructured":"Klebe S, Brownlee NA, Mahar A, Burchette JL, Sporn TA, Vollmer RT, Roggli VL (2010) Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases. Mod Pathol 23:470\u2013479. https:\/\/doi.org\/10.1038\/modpathol.2009.180","journal-title":"Mod Pathol"},{"key":"3048_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/j.semdp.2006.06.002","volume":"23","author":"M Rdzanek","year":"2006","unstructured":"Rdzanek M, Fresco R, Pass HI, Carbone M (2006) Spindle cell tumors of the pleura: differential diagnosis. Semin Diagn Pathol 23:44\u201355. https:\/\/doi.org\/10.1053\/j.semdp.2006.06.002","journal-title":"Semin Diagn Pathol"},{"key":"3048_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/modpathol.3800259","volume":"18","author":"AY Chu","year":"2005","unstructured":"Chu AY, Litzky LA, Pasha TL, Acs G, Zhang P (2005) Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 18:105\u2013110. https:\/\/doi.org\/10.1038\/modpathol.3800259","journal-title":"Mod Pathol"},{"key":"3048_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1440-1827.2007.02193.x","volume":"58","author":"K Kushitani","year":"2008","unstructured":"Kushitani K, Takeshima Y, Amatya VJ, Furonaka O, Sakatani A, Inai K (2008) Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry. Pathol Int 58:75\u201383. https:\/\/doi.org\/10.1111\/j.1440-1827.2007.02193.x","journal-title":"Pathol Int"},{"key":"3048_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/modpathol.3800736","volume":"20","author":"M Hinterberger","year":"2007","unstructured":"Hinterberger M, Reineke T, Storz M, Weder W, Vogt P, Moch H (2007) D2-40 and calretinin- a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation. Mod Pathol 20:248\u2013255. https:\/\/doi.org\/10.1038\/modpathol.3800736","journal-title":"Mod Pathol"},{"key":"3048_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","volume":"142","author":"AN Husain","year":"2018","unstructured":"Husain AN, Colby TV, Ordonez NG, Allen TC, Attanoos RL, Beasley MB, Butnor KJ, Chirieac LR, Churg AM, Dacic S, Galateau-Sall\u00e9 F, Gibbs A, Gown AM, Krausz T, Litzky LA, Marchevsky A, Nicholson AG, Roggli VL, Sharma AK, Travis WD, Walts AE, Wick MR (2018) Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med 142:89\u2013108. https:\/\/doi.org\/10.5858\/arpa.2017-0124-RA","journal-title":"Arch Pathol Lab Med"},{"key":"3048_CR17","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.humpath.2012.12.012","volume":"44","author":"A Chang","year":"2013","unstructured":"Chang A, Brimo F, Montgomery EA, Epstein JI (2013) Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma. Hum Pathol 44:1563\u20131568. https:\/\/doi.org\/10.1016\/j.humpath.2012.12.012","journal-title":"Hum Pathol"},{"key":"3048_CR18","doi-asserted-by":"publisher","first-page":"e0156524","DOI":"10.1371\/journal.pone.0156524","volume":"11","author":"T Haraguchi","year":"2016","unstructured":"Haraguchi T, Miyoshi H, Hiraoka K, Yokoyama S, Ishibashi Y, Hashiguchi T, Matsuda K, Hamada T, Okawa T, Shiba N, Ohshima K (2016) GATA3 expression is a poor prognostic factor in soft tissue sarcomas. PLoS One 11:e0156524. https:\/\/doi.org\/10.1371\/journal.pone.0156524","journal-title":"PLoS One"},{"key":"3048_CR19","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","volume":"28","author":"M Cigognetti","year":"2020","unstructured":"Cigognetti M, Lonardi S, Fisogni S, Balzarini P, Pellegrini V, Tironi A, Bercich L, Bugatti M, Rossi G, Murer B, Barbareschi M, Giuliani S, Cavazza A, Marchetti G, Vermi W, Facchetti F (2020) BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations. Mod Pathol 28:1043\u20131057","journal-title":"Mod Pathol"}],"updated-by":[{"DOI":"10.1007\/s00428-021-03072-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000}}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03048-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-021-03048-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03048-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T19:19:54Z","timestamp":1628968794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-021-03048-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["3048"],"URL":"https:\/\/doi.org\/10.1007\/s00428-021-03048-y","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"10 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00428-021-03072-y","URL":"https:\/\/doi.org\/10.1007\/s00428-021-03072-y","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The data and experiments reported here were performed in accordance with the Declaration of Helsinki principles and the Ethics Committee of the Ningbo Diagnostic Pathology Center.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}